ES2106942T3 - Sales de acidos trans y cis traumaticos que tienen actividad cicatrizante asociada a actividad bacterioestatica, antivirica, antibiotica o antifungica. - Google Patents

Sales de acidos trans y cis traumaticos que tienen actividad cicatrizante asociada a actividad bacterioestatica, antivirica, antibiotica o antifungica.

Info

Publication number
ES2106942T3
ES2106942T3 ES93118531T ES93118531T ES2106942T3 ES 2106942 T3 ES2106942 T3 ES 2106942T3 ES 93118531 T ES93118531 T ES 93118531T ES 93118531 T ES93118531 T ES 93118531T ES 2106942 T3 ES2106942 T3 ES 2106942T3
Authority
ES
Spain
Prior art keywords
traumatic
acid salts
bacterioestatic
antivirical
antibiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93118531T
Other languages
English (en)
Inventor
Valle Francesco Della
Silvana Lorenzi
Gabriele Marcolongo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LifeGroup SpA
Original Assignee
LifeGroup SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LifeGroup SpA filed Critical LifeGroup SpA
Application granted granted Critical
Publication of ES2106942T3 publication Critical patent/ES2106942T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13—Dicarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Abstract

SE DESCRIBEN UNAS SALES DE ACIDO TRAUMATICO, DONDE B ES UN CATION ACTIVO SELECCIONADO DE: A) UN AMONIO CUATERNARIO, B) UN CATION DE UNA MONO-, DI-, O TRI-ALCANOLAMINA C1-C20 RAMIFICADA, C) UN CATION DE UNA AMINA PRIMARIA, SECUNDARIA O TERCIARIA BIOLOGICAMENTE ACTIVA, D) PLATA O CATION DE ZINC, Y UNA COMPOSICION FARMACEUTICA ADMINISTRABLE POR VIA TOPICA O PARENTERAL PARA EL TRATAMIENTO DE PATOLOGIAS CUTANEAS EN LAS CUALES ES IMPORTANTE ASOCIAR UNA ACTIVIDAD ANTIVIRICA, ANTIFUNGICIDA, ANTIBIOTICA O BACETROESTATICA, PARA EL EFECTO CICATRIZANTE TIPICO DEL ACIDO TRAUMATICO.
ES93118531T 1992-11-23 1993-11-18 Sales de acidos trans y cis traumaticos que tienen actividad cicatrizante asociada a actividad bacterioestatica, antivirica, antibiotica o antifungica. Expired - Lifetime ES2106942T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI922674A IT1256111B (it) 1992-11-23 1992-11-23 Sali dell'acido traumatico ad attivita' cicatrizzante ed antibatterica

Publications (1)

Publication Number Publication Date
ES2106942T3 true ES2106942T3 (es) 1997-11-16

Family

ID=11364331

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93118531T Expired - Lifetime ES2106942T3 (es) 1992-11-23 1993-11-18 Sales de acidos trans y cis traumaticos que tienen actividad cicatrizante asociada a actividad bacterioestatica, antivirica, antibiotica o antifungica.

Country Status (10)

Country Link
US (1) US5567716A (es)
EP (1) EP0599188B1 (es)
JP (1) JPH072725A (es)
AT (1) ATE156354T1 (es)
CA (1) CA2109537A1 (es)
DE (1) DE69312870T2 (es)
DK (1) DK0599188T3 (es)
ES (1) ES2106942T3 (es)
GR (1) GR3025074T3 (es)
IT (1) IT1256111B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6576224B1 (en) * 1999-07-06 2003-06-10 Sinuspharma, Inc. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
US20020061281A1 (en) * 1999-07-06 2002-05-23 Osbakken Robert S. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
US6719987B2 (en) 2000-04-17 2004-04-13 Nucryst Pharmaceuticals Corp. Antimicrobial bioabsorbable materials
FR2809310B1 (fr) * 2000-05-26 2004-02-13 Centre Nat Rech Scient Utilisation de derives de biguanide pour fabriquer un medicament ayant un effet cicatrisant
JP2004505057A (ja) 2000-07-27 2004-02-19 ニュクリスト　ファーマシューティカルズ　コーポレーション 過剰増殖性の皮膚障害および皮膚疾患の処置
DE60210441T2 (de) 2001-04-23 2006-11-16 Nucryst Pharmaceuticals Corp., Fort Saskatchewan Arzneimittel oder pflaster enthaltend ein metall wie silber, gold, platin oder palladium als antimikrobiellen wirkstoff und dessen verwendung in der behandlung von hautentzündungen
KR100447825B1 (ko) * 2001-11-23 2004-09-08 주식회사 코리아나화장품 트라마트산을 포함하는 콜라겐 생합성 촉진용 화장료 조성물
US20030133893A1 (en) * 2002-01-15 2003-07-17 Degania Silicone Ltd. Compositions and methods for treating skin ailments
US7201925B2 (en) 2002-04-23 2007-04-10 Nueryst Pharmaceuticals Corp. Treatment of ungual and subungual diseases
US7258875B2 (en) * 2003-12-04 2007-08-21 Chiou Consulting, Inc. Compositions and methods for topical treatment of skin infection
ES2392436T3 (es) 2005-04-19 2012-12-10 Innovet Italia S.R.L. Composiciones farmacéuticas para el tratamiento de ulceraciones crónicas
WO2009085651A1 (en) 2007-12-20 2009-07-09 Nucryst Pharmaceuticals Corp. Metal carbonate particles for use in medicine and methods of making thereof
BRPI0923114A2 (pt) * 2008-12-19 2015-08-11 Pinnacle Pharmaceuticals Inc Compostos de fenazopiridina
ITPI20090027A1 (it) * 2009-03-12 2010-09-13 Filippo Lulli Sali fisiologicamente e biologicamente attivi dell'acido cis-e trans-traumatico per il trattamento di piante monocotiledoni e dicotiledoni
GB201313423D0 (en) 2013-07-26 2013-09-11 Innospec Ltd Compositions and methods
BR112021010407A2 (pt) * 2018-12-06 2021-08-24 International Flavors & Fragrances Inc. Artigo de consumo, e, métodos para realçar a doçura ou sensação bucal de um artigo de consumo e para mascarar um sabor proteináceo desagradável de um artigo de consumo
WO2020118005A1 (en) * 2018-12-06 2020-06-11 International Flavors & Fragrances Inc. Traumatic acid compositions and methods for taste modulation
CN113712950A (zh) * 2021-08-31 2021-11-30 上海市同仁医院 创伤酸在制备抗肥胖药物或抗肥胖保健品中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3532636A (en) * 1968-02-14 1970-10-06 Purex Corp Ltd Detergent composition
US3542826A (en) * 1968-03-22 1970-11-24 Purex Corp Ltd Cobalt dodecenedioate and use thereof
US3720773A (en) * 1970-01-22 1973-03-13 Purex Corp Ltd Method and composition for the topical treatment of herpetic keratitis
US3808314A (en) * 1970-01-22 1974-04-30 Purex Corp Ltd Cobalt dodecenedioate for treating canine pyometritis

Also Published As

Publication number Publication date
DE69312870D1 (de) 1997-09-11
ATE156354T1 (de) 1997-08-15
CA2109537A1 (en) 1994-05-24
EP0599188B1 (en) 1997-08-06
DK0599188T3 (da) 1998-02-02
EP0599188A1 (en) 1994-06-01
IT1256111B (it) 1995-11-28
DE69312870T2 (de) 1998-01-15
ITMI922674A1 (it) 1994-05-23
US5567716A (en) 1996-10-22
GR3025074T3 (en) 1998-01-30
JPH072725A (ja) 1995-01-06
ITMI922674A0 (it) 1992-11-23

Similar Documents

Publication Publication Date Title
ES2106942T3 (es) Sales de acidos trans y cis traumaticos que tienen actividad cicatrizante asociada a actividad bacterioestatica, antivirica, antibiotica o antifungica.
PT97689A (pt) Processo para a preparacao de composicoes farmaceuticas incorporando como ingrediente activo isoxazol-4-carboxilamida e hidroxialquilideno-cianoacetamida
ES2133785T3 (es) Inhibidores de metaloproteinasas.
BR0009043A (pt) Composto, composição farmacêutica, e, método de tratar uma doença em um animal em que a atividade da cisteìna protease contribui para a patologia e/ou sintomatologia da doença
BR0207726A (pt) Sais farmacêuticos
UY27370A1 (es) Derivados de benzamida tiazol y composiciones farmacéuticas para inhibir la proliferación de células y métodos para su utilización
BR9916969A (pt) Antibióticos cetólidos
DE69809489D1 (de) Lösungen als Träger für Augenarzneien
PT96506A (pt) Processo para a preparacao de composicoes orais que incorporam como ingrediente activo pimobendano
ES2034926T1 (es) Composiciones farmaceuticas orales liquidas con actividad anti-inflamatoria.
ES475035A1 (es) Un procedimiento para preparar derivados del acido cefalosporanico.
ES2101858T3 (es) Derivados de geneserina como inhibidores de colinesterasa.
ATE307796T1 (de) Nitratsalz von cetirizine
AR039895A1 (es) Composicion que comprende una vitamina, una sal de metal y una insulina o una hormona del crecimiento y uso de dichos componentes para prepararla
DK0500953T3 (da) Potentiator af antineoplastisk virkning og antineoplastisk middel
AR048929A1 (es) Formas de dosificacion y metodos de tratamiento utilizando inhibidores de vegfr.
MX9300638A (es) Derivados del acido aminobenzoico.
MX9303422A (es) Benzodiazepinas, procedimiento para su preparacion y medicamento que las contiene.
ES2074257T3 (es) Derivados de aminoacidos.
AR013758A1 (es) Terapia de combinacion para el tratamiento de sida.
MX9302818A (es) Agente para incrementar somatostatina o para inhibir la reduccion de somatostatina.
ES2194899T3 (es) Composicion farmaceutica para administracion transdermica sistemica del principio activo morfina-6-glucuronido.
NO910971D0 (no) 1-alkyl-, 1-alkenyl- og 1-alkynylaryl-2-amino-1,3-propandioler og beslektede forbindelser og mellomprodukter, fremgangsmaate for fremstilling og anvendelse som medikamenter.
MX9304642A (es) Nuevo compuesto.
PE2298A1 (es) Metodos para minimizar la perdida osea

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 599188

Country of ref document: ES